BHVN
Price
$11.36
Change
-$0.14 (-1.22%)
Updated
Feb 13 closing price
Capitalization
1.51B
33 days until earnings call
Intraday BUY SELL Signals
TPST
Price
$2.36
Change
+$0.05 (+2.16%)
Updated
Feb 13 closing price
Capitalization
11.58M
Intraday BUY SELL Signals
Interact to see
Advertisement

BHVN vs TPST

Header iconBHVN vs TPST Comparison
Open Charts BHVN vs TPSTBanner chart's image
Biohaven
Price$11.36
Change-$0.14 (-1.22%)
Volume$2.09M
Capitalization1.51B
Tempest Therapeutics
Price$2.36
Change+$0.05 (+2.16%)
Volume$30.87K
Capitalization11.58M
BHVN vs TPST Comparison Chart in %
BHVN
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BHVN vs. TPST commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongBuy and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (BHVN: $11.36 vs. TPST: $2.36)
Brand notoriety: BHVN and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 69% vs. TPST: 29%
Market capitalization -- BHVN: $1.51B vs. TPST: $11.58M
BHVN [@Biotechnology] is valued at $1.51B. TPST’s [@Biotechnology] market capitalization is $11.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, BHVN is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • BHVN’s TA Score: 4 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both BHVN and TPST are a bad buy in the short-term.

Price Growth

BHVN (@Biotechnology) experienced а -2.07% price change this week, while TPST (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

BHVN is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($1.51B) has a higher market cap than TPST($11.6M). BHVN YTD gains are higher at: 0.620 vs. TPST (-17.770). TPST has higher annual earnings (EBITDA): -35.35M vs. BHVN (-782.76M). BHVN has more cash in the bank: 260M vs. TPST (7.51M). TPST has less debt than BHVN: TPST (8.41M) vs BHVN (314M). BHVN (0) and TPST (0) have equivalent revenues.
BHVNTPSTBHVN / TPST
Capitalization1.51B11.6M12,991%
EBITDA-782.76M-35.35M2,214%
Gain YTD0.620-17.770-3%
P/E RatioN/AN/A-
Revenue00-
Total Cash260M7.51M3,460%
Total Debt314M8.41M3,736%
FUNDAMENTALS RATINGS
BHVN vs TPST: Fundamental Ratings
BHVN
TPST
OUTLOOK RATING
1..100
6277
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6095
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (39) in the Pharmaceuticals Major industry is in the same range as BHVN (43). This means that TPST’s stock grew similarly to BHVN’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that TPST’s stock grew similarly to BHVN’s over the last 12 months.

TPST's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that TPST’s stock grew similarly to BHVN’s over the last 12 months.

BHVN's Price Growth Rating (60) in the Pharmaceuticals Major industry is somewhat better than the same rating for TPST (95). This means that BHVN’s stock grew somewhat faster than TPST’s over the last 12 months.

TPST's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that TPST’s stock grew similarly to BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNTPST
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNWIX77.681.28
+1.68%
Easterly Snow Small Cap Value I
CCTRX13.620.17
+1.26%
Columbia Sm Cp Val and Inflection R
JCMVX30.040.21
+0.70%
JPMorgan Mid Cap Value C
DESUX25.880.04
+0.15%
DWS Enhanced Core Equity R6
DWGHX15.33-0.02
-0.13%
American Funds Dvlpg Wld Gr&Inc F2

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with CDXS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-1.22%
CDXS - BHVN
57%
Loosely correlated
+1.69%
OCUL - BHVN
56%
Loosely correlated
-1.99%
TPST - BHVN
56%
Loosely correlated
+2.16%
AGIO - BHVN
55%
Loosely correlated
-0.39%
NTLA - BHVN
55%
Loosely correlated
+2.15%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with ARTV. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+2.16%
ARTV - TPST
89%
Closely correlated
+0.25%
VTGN - TPST
88%
Closely correlated
-7.23%
MREO - TPST
84%
Closely correlated
-4.32%
RZLT - TPST
83%
Closely correlated
+5.79%
LENZ - TPST
82%
Closely correlated
-0.69%
More